Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
about
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV InfectionNative cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cellsRecent Developments in Cellular Immunotherapy for HSCT-Associated Complications3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cellsFusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.Cytokine-Induced Killer Cells As Pharmacological Tools for Cancer Immunotherapy.Equine dendritic cells generated with horse serum have enhanced functionality in comparison to dendritic cells generated with fetal bovine serum.New insights into the phenotype of human dendritic cell populations.CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.Immunological landscape and immunotherapy of hepatocellular carcinoma.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Understanding dendritic cell immunotherapy in ovarian cancer.The development of dendritic cell vaccine-based immunotherapies for glioblastoma.Desirable cytolytic immune effector cell recruitment by interleukin-15 dendritic cells.Development of oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein.Autocrine Type I IFN Signaling in Dendritic Cells Stimulated with Fungal β-Glucans or Lipopolysaccharide Promotes CD8 T Cell Activation.The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.Combining dendritic cells and B cells for presentation of oxidised tumour antigens to CD8+ T cells.Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia.Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.Interleukin-15-Cultured Dendritic Cells Enhance Anti-Tumor Gamma Delta T Cell Functions through IL-15 Secretion.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?Next Generation Cancer Vaccines-Make It Personal!
P2860
Q26775082-E58CC3CA-72CA-43B1-9EDC-388F79A0687CQ27317032-FA24500E-ED9B-4373-AE36-BCAD2F6E87E0Q28079823-7D601F9C-A863-4E50-AC47-38AD3E778088Q30850591-13DCEB0D-7580-43F5-9AC1-73A8B246D617Q33594333-DA6013AF-3F17-455E-8F61-4A813AEF7508Q33875615-A2B7BE2E-8233-46EF-A05D-E6D6D8193EAAQ36193377-3FBE79EB-161F-4D9E-BF6F-EA4517874126Q36526496-F7F33AF7-BFBB-43CD-8A5C-6647D8A9A9BFQ37078990-073D8DDA-9746-46A7-BB4D-8B89F8F3DE4CQ38611895-02DDA83A-9C05-4E60-85A0-2E6A1112CAA2Q38700209-B42A9885-C87F-4DB2-A8F6-5B540174580FQ38808249-3D4309F4-825F-49DB-9AA3-CD5F10F6D2A7Q38990679-0CD7CD3C-7281-4CD4-8F1A-A564B2A8A214Q39014899-4724D254-C1DC-4A73-BE3D-DA52AA9ED832Q40290133-5A1A5C3C-D181-4FC6-9E5B-1BC8A0A5EB11Q40441584-95DB5082-8FFE-4A12-BC2B-451D90DCC549Q41189810-3F72B2E5-E122-4D9C-8FC8-08DAFC72418CQ41205250-02C6AE85-4CAD-4953-8096-07CE04BF8C0AQ43297784-010214BD-26C2-443C-AEBA-65BC2F7B7569Q47614555-0E055223-20E7-43AD-A6CD-3470673CF39EQ52716912-6280074D-7AE1-43F2-9E13-8423C76E9705Q55174561-0F03FB74-90B9-4364-904B-D360A5952394Q57155184-2C61D82D-FB3E-4FE2-B5C2-ADC9D3B1247FQ58791982-1720CD8A-2DB7-43F5-B014-549BA7A2F0CA
P2860
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
@en
type
label
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
@en
prefLabel
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy.
@en
P2093
P50
P356
P1476
Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy
@en
P2093
Christian Bryant
Derek N Hart
Heleen H Van Acker
Herman Goossens
Phillip D Fromm
Sébastien Anguille
Viggo F Van Tendeloo
P304
P356
10.1124/PR.114.009456
P577
2015-10-01T00:00:00Z